Zhu Jianhua, Wang Mingxuan, Wen Wei, Yu Rongmin
Biotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China.
Biotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China ; Department of Natural Medicinal Chemistry, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Pharmacogn Rev. 2015 Jan-Jun;9(17):24-8. doi: 10.4103/0973-7847.156323.
Catharanthus roseus produces a wide range of terpenoid indole alkaloids (TIA). Many of them, such as vinblastine and vincristine, have significant bioactivity. They are valuable chemotherapy drugs used in combination with other drugs to treat lymphoma and leukemia. The TIA biosynthetic pathway has been investigated for many years, for scientific interest and for their potential in manufacturing applications, to fulfill the market demand. In this review, the progress and perspective of C. roseus TIA biosynthesis and its regulating enzymes are described. In addition, the culture condition, hormones, signaling molecules, precursor feeding on the accumulation of TIA, and gene expression are also evaluated and discussed.
长春花能产生多种萜类吲哚生物碱(TIA)。其中许多生物碱,如长春碱和长春新碱,具有显著的生物活性。它们是与其他药物联合使用治疗淋巴瘤和白血病的有价值的化疗药物。多年来,人们一直在研究TIA生物合成途径,既是出于科学兴趣,也是因其在制造应用中的潜力,以满足市场需求。在这篇综述中,描述了长春花TIA生物合成及其调控酶的进展和前景。此外,还对培养条件、激素、信号分子、前体物质添加对TIA积累的影响以及基因表达进行了评估和讨论。